Today, Bill Gates met with Australian Prime Minister Anthony Albanese. One of the topics they discussed was the use of genetically modified (GM) mosquitoes to control dengue fever in Queensland. Here are the details:

NOTIFICATION OF APPLICATION

The Office of the Gene Technology Regulator (OGTR) has received a licence application (DIR 207) from Oxitec Australia Pty Ltd. Oxitec is seeking approval for the commercial release of a genetically modified mosquito strain to reduce the population of Aedes aegypti mosquitoes and help prevent dengue outbreaks in Queensland.

The OGTR is currently preparing a Risk Assessment and Risk Management Plan (RARMP) for this application. This assessment will consider advice from experts, agencies, authorities, and local councils, as required under the Gene Technology Act 2000. The RARMP is expected to be released for public comment in late March 2025, with at least 30 days allocated for submissions.

If you have any questions or would like to obtain a copy of the application or summary, you can contact the OGTR:

Office of the Gene Technology RegulatorMDP 54 GPO Box 9848CANBERRA ACT 2601Telephone: 1800 181 030

Serious Ethical Concerns Raised

In addition to this development, concerns have been raised about past trials involving mosquitoes being used to deliver malaria vaccines. These trials aimed to vaccinate individuals against malaria via mosquito bites. While these trials have been completed, they highlight a serious ethical issue: every human has the fundamental right to choose whether or not to be vaccinated. The idea of using mosquitoes as a delivery mechanism raises significant concerns about consent and personal autonomy.

These technologies warrant careful scrutiny, and it is crucial for the public to remain informed and engaged in discussions about their development and potential implications.